120 related articles for article (PubMed ID: 33188936)
21. Quantitative analysis of γ-H2AX and p53 nuclear expression levels in ovarian and fallopian tube epithelium from risk-reducing salpingo-oophorectomies in BRCA1 and BRCA2 mutation carriers.
Staff S; Tolonen T; Laasanen SL; Mecklin JP; Isola J; Mäenpää J
Int J Gynecol Pathol; 2014 May; 33(3):309-16. PubMed ID: 24681744
[TBL] [Abstract][Full Text] [Related]
22. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
[No Abstract] [Full Text] [Related]
23. Serous borderline tumor of the fallopian tube in a patient with Klippel-Trenaunay syndrome.
Stephens D; Pillai S; Cham E; Arensman R; Chou P
J Pediatr Surg; 2010 Nov; 45(11):2244-6. PubMed ID: 21034953
[TBL] [Abstract][Full Text] [Related]
24. Detection of the BRAF V600E mutation in serous ovarian tumors: a comparative analysis of immunohistochemistry with a mutation-specific monoclonal antibody and allele-specific PCR.
Bösmüller H; Fischer A; Pham DL; Fehm T; Capper D; von Deimling A; Bonzheim I; Staebler A; Fend F
Hum Pathol; 2013 Mar; 44(3):329-35. PubMed ID: 23089489
[TBL] [Abstract][Full Text] [Related]
25. Metaplastic papillary tumor of the salpinx: report of a case using microsatellite analysis.
D'Adda T; Pizzi S; Bottarelli L; Azzoni C; Manni S; Giordano G
Int J Gynecol Pathol; 2011 Nov; 30(6):532-5. PubMed ID: 21979587
[TBL] [Abstract][Full Text] [Related]
26. Fallopian tube precursors of ovarian low- and high-grade serous neoplasms.
Vang R; Shih IeM; Kurman RJ
Histopathology; 2013 Jan; 62(1):44-58. PubMed ID: 23240669
[TBL] [Abstract][Full Text] [Related]
27. Usefulness of immunohistochemistry for the detection of the BRAF V600E mutation in ovarian serous borderline tumors.
Hayashi Y; Sasaki H; Takeshita S; Nishikawa R; Nishikawa H; Arakawa A; Yamashita Y; Takahashi S; Sugiura-Ogasawara M
Oncol Rep; 2014 Nov; 32(5):1815-9. PubMed ID: 25174456
[TBL] [Abstract][Full Text] [Related]
28. Interobserver Reproducibility in Assessing Eosinophilic Cells in Ovarian Serous Borderline Tumors to Predict BRAF Mutational Status.
Chui MH; Murali R; Soslow RA; Matrai C; Xing D; Vang R
Int J Gynecol Pathol; 2023 Sep; 42(5):472-481. PubMed ID: 36867514
[TBL] [Abstract][Full Text] [Related]
29. [The Fallopian tube odyssey: from the ovary to the tube. About high-grade serous ovarian carcinoma].
Chêne G; Dauplat J; Radosevic-Robin N; Cayre A; Penault-Llorca F
Bull Cancer; 2013; 100(7-8):757-64. PubMed ID: 23831931
[TBL] [Abstract][Full Text] [Related]
30. Serous papillary cystadenofibroma of the fallopian tube: A case report and short review of literature.
Khatib Y; Patel RD; Kashikar AS; Chavan K
Indian J Pathol Microbiol; 2015; 58(4):524-7. PubMed ID: 26549083
[TBL] [Abstract][Full Text] [Related]
31. v-Raf murine sarcoma viral oncogene mutation status in serous borderline ovarian tumors and the effect on clinical behavior.
Verbruggen MB; Sieben NL; Roemen GM; Rockx DA; van Diest PJ; Verheijen RH; Dorsman JC
Int J Gynecol Cancer; 2009 Dec; 19(9):1560-3. PubMed ID: 19955937
[TBL] [Abstract][Full Text] [Related]
32. Ovarian-type epithelial tumours of the testis: immunohistochemical and molecular analysis of two serous borderline tumours of the testis.
Bürger T; Schildhaus HU; Inniger R; Hansen J; Mayer P; Schweyer S; Radzun HJ; Ströbel P; Bremmer F
Diagn Pathol; 2015 Jul; 10():118. PubMed ID: 26197800
[TBL] [Abstract][Full Text] [Related]
33. Mutation of NRAS is a rare genetic event in ovarian low-grade serous carcinoma.
Xing D; Suryo Rahmanto Y; Zeppernick F; Hannibal CG; Kjaer SK; Vang R; Shih IM; Wang TL
Hum Pathol; 2017 Oct; 68():87-91. PubMed ID: 28873354
[TBL] [Abstract][Full Text] [Related]
34. A candidate precursor to serous carcinoma that originates in the distal fallopian tube.
Lee Y; Miron A; Drapkin R; Nucci MR; Medeiros F; Saleemuddin A; Garber J; Birch C; Mou H; Gordon RW; Cramer DW; McKeon FD; Crum CP
J Pathol; 2007 Jan; 211(1):26-35. PubMed ID: 17117391
[TBL] [Abstract][Full Text] [Related]
35. Papilloma of the Fallopian Tube: A Rare Gynecologic Neoplasm Harboring a BRAF (c.1799T>A) Mutation (V600E).
Wohlschlaeger J; Davidson B; Worm K; Feist H; Peters J; Hager T; Schmid KW; Ostertag H
Int J Gynecol Pathol; 2019 Sep; 38(5):459-463. PubMed ID: 29851866
[TBL] [Abstract][Full Text] [Related]
36. Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma.
Salvador S; Rempel A; Soslow RA; Gilks B; Huntsman D; Miller D
Gynecol Oncol; 2008 Sep; 110(3):408-17. PubMed ID: 18597838
[TBL] [Abstract][Full Text] [Related]
37. Serous borderline tumor of the fallopian tube presented as hematosalpinx: a case report.
Krasevic M; Stankovic T; Petrovic O; Smiljan-Severinski N
BMC Cancer; 2005 Oct; 5():129. PubMed ID: 16212662
[TBL] [Abstract][Full Text] [Related]
38. BRAF
Turashvili G; Grisham RN; Chiang S; DeLair DF; Park KJ; Soslow RA; Murali R
Histopathology; 2018 Sep; 73(3):438-443. PubMed ID: 29770477
[TBL] [Abstract][Full Text] [Related]
39. Paratubal borderline tumor diagnosed in the adolescent period: a case report and review of the literature.
Terek MC; Sahin C; Yeniel AO; Ergenoglu M; Zekioglu O
J Pediatr Adolesc Gynecol; 2011 Oct; 24(5):e115-6. PubMed ID: 21737318
[TBL] [Abstract][Full Text] [Related]
40. Evidence for lineage continuity between early serous proliferations (ESPs) in the Fallopian tube and disseminated high-grade serous carcinomas.
Soong TR; Howitt BE; Miron A; Horowitz NS; Campbell F; Feltmate CM; Muto MG; Berkowitz RS; Nucci MR; Xian W; Crum CP
J Pathol; 2018 Nov; 246(3):344-351. PubMed ID: 30043522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
